Irhythm Technologies [IRTC] vs Globus Medical [GMED] Detailed Stock Comparison
Irhythm Technologies
NASDAQ
Loading...
Globus Medical
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Irhythm Technologies wins in 6 metrics, Globus Medical wins in 12 metrics, with 0 ties. Globus Medical appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Irhythm Technologies | Globus Medical | Better |
|---|---|---|---|
| P/E Ratio (TTM) | -43.66 | 43.77 | Irhythm Technologies |
| Price-to-Book Ratio | 49.09 | 1.84 | Globus Medical |
| Debt-to-Equity Ratio | 708.80 | 2.83 | Globus Medical |
| PEG Ratio | -86.14 | 17.15 | Irhythm Technologies |
| EV/EBITDA | -111.34 | 10.62 | Irhythm Technologies |
| Profit Margin (TTM) | -14.06% | 13.58% | Globus Medical |
| Operating Margin (TTM) | -5.71% | 17.33% | Globus Medical |
| EBITDA Margin (TTM) | N/A | 17.33% | N/A |
| Return on Equity | -91.14% | 8.62% | Globus Medical |
| Return on Assets (TTM) | -3.53% | 5.82% | Globus Medical |
| Free Cash Flow (TTM) | $-45.55M | $405.21M | Globus Medical |
| 1-Year Return | 123.27% | -19.88% | Irhythm Technologies |
| Price-to-Sales Ratio (TTM) | 7.75 | 3.02 | Globus Medical |
| Enterprise Value | $5.28B | $7.81B | Globus Medical |
| EV/Revenue Ratio | 8.04 | 2.98 | Globus Medical |
| Gross Profit Margin (TTM) | 71.17% | 67.33% | Irhythm Technologies |
| Revenue per Share (TTM) | $21 | $19 | Irhythm Technologies |
| Earnings per Share (Diluted) | $-2.92 | $1.34 | Globus Medical |
| Beta (Stock Volatility) | 1.41 | 1.20 | Globus Medical |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Irhythm Technologies vs Globus Medical Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Irhythm Technologies | -1.55% | -3.92% | 17.73% | 15.69% | 44.75% | 77.21% |
| Globus Medical | 8.47% | 11.42% | 3.62% | -19.06% | -32.88% | -28.33% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Irhythm Technologies | 123.27% | 4.68% | -8.36% | 514.58% | 514.58% | 514.58% |
| Globus Medical | -19.88% | -12.03% | 6.93% | 121.15% | 334.44% | 334.44% |
Performance & Financial Health Analysis: Irhythm Technologies vs Globus Medical
| Metric | IRTC | GMED |
|---|---|---|
| Market Information | ||
| Market Cap | $5.09B | $7.92B |
| Market Cap Category | Mid cap | Mid cap |
| 10 Day Avg. Volume | 678,940 | 1,536,240 |
| 90 Day Avg. Volume | 508,497 | 1,652,257 |
| Last Close | $158.50 | $58.65 |
| 52 Week Range | $55.92 - $168.32 | $51.79 - $94.93 |
| % from 52W High | -5.83% | -38.22% |
| All-Time High | $286.19 (Jan 25, 2021) | $94.93 (Jan 27, 2025) |
| % from All-Time High | -44.62% | -38.22% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.26% | 0.18% |
| Quarterly Earnings Growth | 0.26% | 5.39% |
| Financial Health | ||
| Profit Margin (TTM) | -0.14% | 0.14% |
| Operating Margin (TTM) | -0.06% | 0.17% |
| Return on Equity (TTM) | -0.91% | 0.09% |
| Debt to Equity (MRQ) | 708.80 | 2.83 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $3.23 | $31.81 |
| Cash per Share (MRQ) | $16.98 | $1.70 |
| Operating Cash Flow (TTM) | $63.35M | $669.16M |
| Levered Free Cash Flow (TTM) | $47.56M | $456.11M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Irhythm Technologies vs Globus Medical
| Metric | IRTC | GMED |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | -43.66 | 43.77 |
| Forward P/E | -86.14 | 17.15 |
| PEG Ratio | -86.14 | 17.15 |
| Price to Sales (TTM) | 7.75 | 3.02 |
| Price to Book (MRQ) | 49.09 | 1.84 |
| Market Capitalization | ||
| Market Capitalization | $5.09B | $7.92B |
| Enterprise Value | $5.28B | $7.81B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 8.04 | 2.98 |
| Enterprise to EBITDA | -111.34 | 10.62 |
| Risk & Other Metrics | ||
| Beta | 1.41 | 1.20 |
| Book Value per Share (MRQ) | $3.23 | $31.81 |
Financial Statements Comparison: Irhythm Technologies vs Globus Medical
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | IRTC | GMED |
|---|---|---|
| Revenue/Sales | $158.68M | $598.12M |
| Cost of Goods Sold | $49.46M | $195.40M |
| Gross Profit | $109.22M | $402.72M |
| Research & Development | $21.82M | $33.06M |
| Operating Income (EBIT) | $-32.56M | $98.06M |
| EBITDA | $-20.95M | $160.92M |
| Pre-Tax Income | $-30.04M | $103.67M |
| Income Tax | $665,000 | $28.21M |
| Net Income (Profit) | $-30.70M | $75.46M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | IRTC | GMED |
|---|---|---|
| Cash & Equivalents | $375.28M | $461.27M |
| Total Current Assets | $636.01M | $1.71B |
| Total Current Liabilities | $111.34M | $384.70M |
| Long-Term Debt | $719.36M | $81.69M |
| Total Shareholders Equity | $86.67M | $4.09B |
| Retained Earnings | $-789.60M | $1.04B |
| Property, Plant & Equipment | $55.71M | $1.06B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | IRTC | GMED |
|---|---|---|
| Operating Cash Flow | $-31.20M | $193.84M |
| Capital Expenditures | $-9.42M | $-36.10M |
| Free Cash Flow | $-17.31M | $136.20M |
| Debt Repayment | $0 | $-449.99M |
| Common Stock Repurchase | $0 | $-190.45M |
Short Interest & Institutional Ownership Analysis
| Metric | IRTC | GMED |
|---|---|---|
| Shares Short | 2.49M | 4.52M |
| Short Ratio | 5.55 | 3.01 |
| Short % of Float | 0.09% | 0.04% |
| Average Daily Volume (10 Day) | 678,940 | 1,536,240 |
| Average Daily Volume (90 Day) | 508,497 | 1,652,257 |
| Shares Outstanding | 31.39M | 137.42M |
| Float Shares | 31.74M | 111.79M |
| % Held by Insiders | 0.01% | 0.01% |
| % Held by Institutions | 1.14% | 1.02% |
Dividend Analysis & Yield Comparison: Irhythm Technologies vs Globus Medical
| Metric | IRTC | GMED |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |